Clinical Trials 979 Views Bavarian Nordic initiates global Phase 3 trial Malin Otmani April 20, 2022 Bavarian Nordic has announced the …
Agreement 879 Views Bavarian Nordic enters license and supply agreement Malin Otmani March 21, 2022 Bavarian Nordic has entered into …
Pharma Business 852 Views Bavarian Nordic receives Breakthrough Therapy Designation Malin Otmani February 28, 2022 The U.S. Food and Drug …
Clinical Trials 1643 Views Bavarian Nordic initiates Phase I trial Malin Otmani October 16, 2019 The company has initiated the …
Clinical Trials 2439 Views Positive results from Bavarian Nordic Malin Otmani February 7, 2018 Bavarian Nordic announces positive results …
Biotech Business 2639 Views Bavarian Nordic enters research collaboration Malin Otmani February 23, 2016 Bavarian Nordic has entered into …
Collaboration 1889 Views Bavarian Nordic collaborates with Janssen Malin Otmani January 8, 2016 Janssen Pharmaceuticals has entered into …
Acquisition 1460 Views Bavarian Nordic Gets Loan Ellen R. Delisio May 18, 2015 Bavarian Nordic has secured a …
Clinical Trials 2520 Views Solid Tests for Smallpox Vaccine Ellen R. Delisio May 15, 2015 Results of two pivotal Phase …
Clinical Trials 1704 Views Ebola Vaccine Regimen Tested Ellen R. Delisio May 14, 2015 Preliminary results from a Phase …
Drug Development Pharma 1311 Views Bavarian Nordic to Present Findings at Symposium Ellen R. Delisio February 25, 2015 Bavarian Nordic plans to present …
Clinical Trials 1634 Views Bavarian Nordic vs Ebola Ellen R. Delisio December 8, 2014 Denmark’s Bavarian Nordic announced Dec. …
Clinical Trials 2002 Views Bavarian Nordic accelerates Ebola vaccine development Anneli Hidalgo September 8, 2014 Bavarian Nordic A/S will accelerate its …
Acquisition 1596 Views Multi-million dollar contract for Bavarian Nordic Anneli Hidalgo April 29, 2013 Danish Bavarian Nordic receives contract …
Biotech Business 3751 Views Bavarian Nordic consolidates vaccine manufacturing in Denmark Malin Otmani February 27, 2013 The company will consolidate its …
